PD-L1 immuno-expression assay in thymomas: Study of 84 cases and review of literature
Author:
Publisher
Elsevier BV
Subject
General Medicine,Pathology and Forensic Medicine
Reference39 articles.
1. Novel agents in the treatment of Thymic malignancies;du Vignaux;Curr Treat Options Oncol,2017
2. Non-surgical treatment of locally advanced thymic epithelial tumors—a need for multicenter trials;Roden;J Thorac Dis,2016
3. New modalities of cancer treatment for NSCLC: focus on immunotherapy;Davies;Cancer Manag Res,2014
4. PD-L1 expression in human cancers and its association with clinical outcomes;Wang;Onco Targets Ther,2016
5. New findings on thymic epithelial tumors: something is changing;Berardi;World J Clin Oncol,2015
Cited by 15 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Depiction of the Genetic Alterations and Molecular Landscapes of Thymic Epithelial Tumors: A Systematic Review and Meta-Analysis;Cancers;2024-08-25
2. Immunotherapy in thymic epithelial tumors: tissue predictive biomarkers for immune checkpoint inhibitors;Exploration of Targeted Anti-tumor Therapy;2024-05-21
3. Molecular and Functional Key Features and Oncogenic Drivers in Thymic Carcinomas;Cancers;2023-12-29
4. Immunotherapy of thymic epithelial tumors: molecular understandings and clinical perspectives;Molecular Cancer;2023-04-13
5. Expression of Programmed Cell Death 1 Ligand 2 in Patients With Thymoma and Thymomatous Myasthenia Gravis;American Journal of Clinical Pathology;2022-10-07
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3